NEAT1 and prostate cancer: Knockdown of NEAT1 can decrease the malignant behavior of tumor cells for breast cancer [17, 18], hepatocellular carcinoma [19], laryngeal squamous cell carcinoma [20], lung cancer [21], glioma [22], prostate cancer [23], and skin cancer [24].